+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North American Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology [External Neuromodulation and Internal Neuromodulation], Application, and End User and Country

  • ID: 5231374
  • Report
  • November 2020
  • Region: North America, United States
  • 108 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
According to the latest study on‘Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology, Application, End User, and Country’ the North AmericaNeuromodulationmarket was valued at US$ 3,029.72 million in 2019 and is projected to reach US$ 6,612.00 million by 2027; it is expected to grow at a CAGR of 10.6% during 2020-2027. The report highlights the trends prevailing in the North Americaneuromodulation market and the factors driving the market along with those that act as deterrents to its growth.

Based on technology, the neuromodulation market is segmented external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment accounted for the largest share of the North America neuromodulation market. The growth of the segment attributes to growth of internal neuromodulation segment is attributed to increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology are some of the primary factors contributing to the dominance of the segment in the North America Neuromodulation market. Additionally, the outbreak of the COVID-19 pandemic has highly affected the countries in the North American region.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim. are among the prominent players present in the neuromodulation market. The market players are focused on mergers and acquisitions to sustain their position in the market. For instance, in September 2020Boston Scientific announced the European launch of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs), offers expanded personalization based on patient needs, including rechargeable and non-rechargeable options, and access to waveforms that can cover multiple areas of pain.

Reasons to Buy
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the North American neuromodulation Market
  • Highlights key business priorities to assist companies in order to realign their business strategies
  • Highlights key findings and recommendations of crucial progressive industry trends in the North American neuromodulation Market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinizes in-depth North American Market trends and outlook coupled with the factors driving the Market, as well as those hindering it
  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Neuromodulation Market - by Technology
1.3.2 Neuromodulation Market - by Application
1.3.3 Neuromodulation Market - by End User
1.3.4 North America Neuromodulation Market - by Country

2. Neuromodulation Market - Key Takeaways
2.1 Coverage
2.2 Secondary Research
2.3 Primary Research

3. North America Neuromodulation- Market Landscape
3.1 Overview
3.2 PEST Analysis
3.2.1 Expert Opinions

4. Neuromodulation Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Incidence of Neurological Disorders
4.1.2 Growing Developments in Neuromodulation Technology
4.2 Market Restraints
4.2.1 High Cost of Neuromodulation Devices
4.3 Market Opportunities
4.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
4.4 Future Trends
4.4.1 Technological Advancements
4.5 Impact Analysis

5. Neuromodulation Market Analysis - by Technology
5.1 Overview
5.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
5.3 External Neuromodulation
5.3.1 Overview
5.3.2 External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.3.3 Respiratory Electrical Stimulation (RES)
5.3.3.1 Overview
5.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
5.3.4.1 Overview
5.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.3.5 Transcranial Magnetic Stimulation (TMS)
5.3.5.1 Overview
5.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.4 Internal Neuromodulation
5.4.1 Overview
5.4.2 Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.4.3 Deep Brain Stimulation (DBS)
5.4.3.1 Overview
5.4.3.2 Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.4.4 Sacral Nerve Stimulation (DBS)
5.4.4.1 Overview
5.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.4.5 Gastric Electric Stimulation (GES)
5.4.5.1 Overview
5.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.4.6 Spinal Cord Stimulation (SCS)
5.4.6.1 Overview
5.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
5.4.7 Vagus Nerve Stimulation (VNS)
5.4.7.1 Overview
5.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

6. Neuromodulation Market Analysis - by Application
6.1 Overview
6.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
6.3 Chronic Pain Management
6.3.1 Overview
6.3.2 Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4 Failed Back Syndrome
6.4.1 Overview
6.4.2 Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.5 Epilepsy
6.5.1 Overview
6.5.2 Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.6 Tremor
6.6.1 Overview
6.6.2 Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.7 Incontinence
6.7.1 Overview
6.7.2 Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.8 Depression
6.8.1 Overview
6.8.2 Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.9 Dystonia
6.9.1 Overview
6.9.2 Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.10 Gastroparesis
6.10.1 Overview
6.10.2 Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.11 Parkinson’s Disease
6.11.1 Overview
6.11.2 Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.12 Obsessive-Compulsive Disorder (OCD)
6.12.1 Overview
6.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.13 Migraine
6.13.1 Overview
6.13.2 Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

7. Neuromodulation Market Analysis - by End User
7.1 Overview
7.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Clinics
7.4.1 Overview
7.4.2 Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Home Healthcare
7.5.1 Overview
7.5.2 Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

8. Neuromodulation Market Analysis and Forecasts to 2027 - Regional Analysis
8.1 North America: Neuromodulation Market
8.1.1 Overview
8.1.2 North America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
8.1.3 North America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
8.1.3.1 North America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.3.2 North America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.4 North America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.1.5 North America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
8.1.6 North America: Neuromodulation Market, by Country, 2019 & 2027 (%)
8.1.7 US: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
8.1.7.1 US: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
8.1.7.2 US: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
8.1.7.2.1 US: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.7.2.2 US: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.7.3 US: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.1.7.4 US: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
8.1.8 Canada: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
8.1.8.1 Canada: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
8.1.8.2 Canada: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
8.1.8.2.1 Canada: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.8.2.2 Canada: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.8.3 Canada: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.1.8.4 Canada: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
8.1.9 Mexico: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
8.1.9.1 Mexico: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
8.1.9.2 Mexico: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
8.1.9.2.1 Mexico: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.9.2.2 Mexico: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
8.1.9.3 Mexico: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.1.9.4 Mexico: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Impact of COVID-19 Pandemic on North America Neuromodulation Market
8.2 North America: Impact Assessment of COVID-19 Pandemic

9. Company Profiles
9.1 Abbott
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Products and Services
9.1.4 Financial Overview
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Boston Scientific Corporation
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Products and Services
9.2.4 Financial Overview
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 Medtronic
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Products and Services
9.3.4 Financial Overview
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 NeuroPace, Inc.
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Products and Services
9.4.4 Financial Overview
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 NeuroSigma, Inc.
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Products and Services
9.5.4 Financial Overview
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Nevro Corp.
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Products and Services
9.6.4 Financial Overview
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Synapse Biomedical Inc.
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Products and Services
9.7.4 Financial Overview
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Soterix Medical Inc
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Products and Services
9.8.4 Financial Overview
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Integer Holdings Corporation
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Products and Services
9.9.4 Financial Overview
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Magstim
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Products and Services
9.10.4 Financial Overview
9.10.5 SWOT Analysis
9.10.6 Key Developments

10. Appendix
10.1 Glossary of Terms

List of Tables
Table 1. North America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 2. North America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. US: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 7. US: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. US: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. US: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. US: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms, Neuromodulation Market

List of Figures
Figure 1. Neuromodulation Market Segmentation
Figure 2. Neuromodulation Market - by Geography
Figure 3. North America Neuromodulation Market Overview
Figure 4. Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market
Figure 5. Asia-Pacific Region is Expected to show Remarkable Growth during the Forecast Period
Figure 6. North America Neuromodulation Market - Leading Country Markets (US$ Million)
Figure 7. Research Methodology
Figure 8. North America PEST Analysis
Figure 9. Neuromodulation Market Impact Analysis of Drivers and Restraint
Figure 10. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
Figure 11. External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Gastric Electric Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Neuromodulation Market Share, by Application, 2019 and 2027 (%)
Figure 22. Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Neuromodulation Market Share, by End User, 2019 and 2027 (%)
Figure 34. Hospitals Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 36. Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 37. North America: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
Figure 38. North America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 39. North America: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 40. US: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. Canada: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Mexico: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Impact of COVID-19 Pandemic in North American Country Markets
Note: Product cover images may vary from those shown
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
Note: Product cover images may vary from those shown
Adroll
adroll